by marc.wagner | Nov 16, 2022
by marcbacon | Nov 10, 2022
A novel phenotypic approach to CNS drug discovery November 10, 2022 · Drug Discovery World The newest addition to the free DDW podcast is the In Conversation With series, where DDW speaks with members of the drug discovery industry about their work and how it helps...
by marcbacon | Oct 24, 2022
4 next-gen CNS drug development trends By Brian Buntz · October 24, 2022 · Drug Discovery & Development The past couple of years have had a significant impact on CNS drug development, but it remains difficult to gauge how the field will evolve in the coming years....
by marcbacon | Oct 12, 2022
CNS-focused contract research organization PsychoGenics has forged a collaboration with clinical-stage biotech Emyria Ltd to study five novel MDMA-inspired drug candidates for severe neuropsychiatric conditions. Emyria and its partner, the University of...
by Kelly Morris | Oct 10, 2022
